乐观
$4.41
情景价格
$0.255
+0.011 (+4.12%)收盘时
Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.
Given the current price of 0.27555 and a troubling RSI of 7.735, which indicates that the stock is heavily oversold, it may seem tempting to buy. However, the company has reported a staggering 79.59% decline year-to-date and a net income loss of -27500000 in the latest quarter, which raises significant red flags. The ongoing litigation risks and a gross margin that has dropped to 24.21% further complicate the investment case. Therefore, despite the oversold conditions, the fundamental weaknesses and risks suggest that this is not a good buy right now.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Bioceres Reports 2026 Fiscal Year Financial Highlights

Bioceres to Host Conference Call for Q4 and Full Year Results

Bioceres (BIOX) Q3 2026 Earnings Transcript

Bioceres (BIOX) Q1 2026 Earnings Transcript

Bioceres Crop Solutions Earnings Call Insights
Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops. It operates in the Basic Materials sector.
Given the current price of 0.27555 and a troubling RSI of 7.735, which indicates that the stock is heavily oversold, it may seem tempting to buy. However, the company has reported a staggering 79.59% decline year-to-date and a net income loss of -27500000 in the latest quarter, which raises significant red flags. The ongoing litigation risks and a gross margin that has dropped to 24.21% further complicate the investment case. Therefore, despite the oversold conditions, the fundamental weaknesses and risks suggest that this is not a good buy right now.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。